HYDRALAZINE? ESSENTIAL OR HAS A POTENTIAL FOR COMPLICATIONS IN DERMATOLOGY
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2015, Vol 2, Issue 7
Abstract
: BACKGROUND: Hydralazine is a drug which is vasodilator, it lowers blood pressure and allows blood to flow more easily in veins and arteries. Hydralazine is used to treat hypertension. OBJECTIVES: The purpose of this prospective study is to determine role of – Hydralazine in dermatological complications. METHODS: In this descriptive, prospective, observational, cross sectional study, all patients who presented to the department of dermatology during this study period of 12 months from January 2010-December 2010 in. were included. RESULTS: Total number of males in the present study was 19(74%), females in the study was 6(26%). Mean age was 55.28±15.74 (SD) years, number of patients in the age group 31-40 years was 3(12%), 41-50 years was 5(20%), 51-60 years was 7(28%), number of patients in 61-70 years was 4(16%), number of patients in the age group 71-80 years was 4(16%), number of patients in the age group 71-80 years was 2(8%). Maximum number of patients was in their middle age between 41-60 years. Flushing was seen in 8(32%) patients, Urticarial rashes were seen in 10(40%) patients, Lupus-like syndrome was seen in 5(20%) patients, Hypersensitivity reactions was seen in 5(20%) patients, ANA-positivity was seen in 5(20%) patients, out of all the dermatological manifestations Urticarial rashes were seen in maximum number of patients i.e., in 10(40%) patients. Lupus-like syndrome was seen in 5(20%) patients all of whom belonged to the age group 31-60 years. Flushing was seen in 6 (31.57%) patients in males, Urticarial rashes were seen in 8(42.10%) male, lupus like syndrome was seen in 5(26.31%) males, hypersensitivity was seen in 4(21.05%) males and ANA positivity was seen in 5(26.31%) males. Flushing was seen in 2(33.33%) patients in females, Urticarial rashes were seen in 2(33.33%) females, hypersensitivity was seen in 1(16.66%) females and ANA positivity & lupus like syndrome was not seen in females. P value of all symptoms being insignificant. CONCLUSION: There is significant percentage of patients who report with dermatological manifestations with hydralazine in first 6months after initiation as an add on drug.
Authors and Affiliations
Satish K. S, Chanabasappa Mendagudli, Neelima Ravipati
Keywords
Related Articles
- EP ID EP223158
- DOI 10.18410/jebmh/2015/112
- Views 127
- Downloads 0
STUDY ON AWARENESS OF DELETERIOUS EFFECTS OF TOBACCO AND ALCOHOL ON ORAL AND GENERAL HEALTH IN SRIKAKULAM (A. P.) POPULATION
BACKGROUND Tobacco was first brought to India by Portuguese merchants 400 years ago. Every house in the Portuguese colony took up the new fashion of smoking or chewing tobacco. Later British introduced modern commercial...
PREVALENCE OF HYPOMAGNESAEMIA AND ITS PROGNOSTIC VALUE IN CRITICALLY-ILL MEDICAL PATIENTS
BACKGROUND Serum magnesium levels in critically-ill ICU patients and its correlation with the prognosis of the patients have been studied. Low serum magnesium levels were seen in critically ill and it was associated incr...
A CLINICAL STUDY ON THE AETIOPATHOGENESIS OF GLAUCOMA ASSOCIATED WITH TRAUMA
BACKGROUND The aim of the study is to analyse the types of glaucoma associated with trauma and to study the causative mechanism of glaucoma associated with trauma. MATERIAL AND METHODS 100 patients with glaucoma followin...
ACUTE LEUKAEMIA IMMUNOPHENOTYPING BY IMMUNOHISTOCHEMISTRY IN BONE MARROW TREPHINE BIOPSY SECTIONS
BACKGROUND Classification of acute leukaemia is gaining importance as the treatment continues to evolve for specific genetic and pathogenetic subgroups. AIMS: A well organised panel of antibodies can be used for immunoph...
POWER POINT PRESENTATION – MODERN TOOL OF TEACHING AND LEARNING
Microsoft Power Point - It is a program of slide show presentation officially launched on 22.05.1990. HISTORY: Power Point was originally developed by Bob Gaskins. Initially it was called 'Presenter'. Later it was rename...